Brilacidin, a COVID‐19 drug candidate, demonstrates broad‐spectrum antiviral activity against human coronaviruses OC43, 229E, and NL63 through targeting both the virus and the host cell
出版年份 2022 全文链接
标题
Brilacidin, a COVID‐19 drug candidate, demonstrates broad‐spectrum antiviral activity against human coronaviruses OC43, 229E, and NL63 through targeting both the virus and the host cell
作者
关键词
-
出版物
JOURNAL OF MEDICAL VIROLOGY
Volume -, Issue -, Pages -
出版商
Wiley
发表日期
2022-01-26
DOI
10.1002/jmv.27616
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies
- (2021) Dami A. Collier et al. NATURE
- Brilacidin Demonstrates Inhibition of SARS-CoV-2 in Cell Culture
- (2021) Allison Bakovic et al. Viruses-Basel
- Boceprevir, Calpain Inhibitors II and XII, and GC-376 Have Broad-Spectrum Antiviral Activity against Coronaviruses
- (2021) Yanmei Hu et al. ACS Infectious Diseases
- Inflammation, immunity and potential target therapy of SARS-COV-2: A total scale analysis review
- (2021) Shukur Wasman Smail et al. FOOD AND CHEMICAL TOXICOLOGY
- Expedited Approach toward the Rational Design of Noncovalent SARS-CoV-2 Main Protease Inhibitors
- (2021) Naoya Kitamura et al. JOURNAL OF MEDICINAL CHEMISTRY
- SARS-CoV-2 evolution and vaccines: cause for concern?
- (2021) Thomas C Williams et al. Lancet Respiratory Medicine
- Discovery of Potent and Broad-Spectrum Pyrazolopyridine-Containing Antivirals against Enteroviruses D68, A71, and Coxsackievirus B3 by Targeting the Viral 2C Protein
- (2021) Yanmei Hu et al. JOURNAL OF MEDICINAL CHEMISTRY
- Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant
- (2021) Jamie Lopez Bernal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Strategies to target SARS-CoV-2 entry and infection using dual mechanisms of inhibition by acidification inhibitors
- (2021) Chaitra Prabhakara et al. PLoS Pathogens
- Rapid, reliable, and reproducible cell fusion assay to quantify SARS-Cov-2 spike interaction with hACE2
- (2021) Min Zhao et al. PLoS Pathogens
- Heparan Sulfate Proteoglycans as Attachment Factor for SARS-CoV-2
- (2021) Lin Liu et al. ACS Central Science
- The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health — The latest 2019 novel coronavirus outbreak in Wuhan, China
- (2020) David S. Hui et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Triple artemisinin-based combination therapies versus artemisinin-based combination therapies for uncomplicated Plasmodium falciparum malaria: a multicentre, open-label, randomised clinical trial
- (2020) Rob W van der Pluijm et al. LANCET
- Analysis of the susceptibility of lung cancer patients to SARS-CoV-2 infection
- (2020) Qi Kong et al. Molecular Cancer
- Cell entry mechanisms of SARS-CoV-2
- (2020) Jian Shang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Protocol and Reagents for Pseudotyping Lentiviral Particles with SARS-CoV-2 Spike Protein for Neutralization Assays
- (2020) Katharine H. D. Crawford et al. Viruses-Basel
- Development of broad-spectrum enterovirus antivirals based on quinoline scaffold
- (2020) Rami Musharrafieh et al. BIOORGANIC CHEMISTRY
- Boceprevir, GC-376, and calpain inhibitors II, XII inhibit SARS-CoV-2 viral replication by targeting the viral main protease
- (2020) Chunlong Ma et al. CELL RESEARCH
- The value of antimicrobial peptides in the age of resistance
- (2020) Maria Magana et al. LANCET INFECTIOUS DISEASES
- Pharmacological Characterization of the Mechanism of Action of R523062, a Promising Antiviral for Enterovirus D68
- (2020) Chunlong Ma et al. ACS Infectious Diseases
- Characterization of heparin and severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) spike glycoprotein binding interactions
- (2020) So Young Kim et al. ANTIVIRAL RESEARCH
- SARS-CoV-2 Infection Depends on Cellular Heparan Sulfate and ACE2
- (2020) Thomas Mandel Clausen et al. CELL
- Heparin-binding Peptides as Novel Therapies to Stop SARS-CoV-2 Cellular Entry and Infection
- (2020) Omid Tavassoly et al. MOLECULAR PHARMACOLOGY
- From Antimicrobial to Anticancer Peptides: The Transformation of Peptides
- (2019) Yuan Qin et al. Recent Patents on Anti-Cancer Drug Discovery
- Membrane protein of HCoV-NL63 is responsible for interaction with the adhesion receptor.
- (2019) Antonina Naskalska et al. JOURNAL OF VIROLOGY
- The Antimicrobial Peptide Database provides a platform for decoding the design principles of naturally occurring antimicrobial peptides
- (2019) Guangshun Wang PROTEIN SCIENCE
- Human Antimicrobial Peptides as Therapeutics for Viral Infections
- (2019) Aslaa Ahmed et al. Viruses-Basel
- Heparan Sulfate Proteoglycans and Viral Attachment: True Receptors or Adaptation Bias?
- (2019) Cagno et al. Viruses-Basel
- A novel druggable interprotomer pocket in the capsid of rhino- and enteroviruses
- (2019) Rana Abdelnabi et al. PLOS BIOLOGY
- A Novel Capsid Binding Inhibitor Displays Potent Antiviral Activity against Enterovirus D68
- (2019) Chunlong Ma et al. ACS Infectious Diseases
- Discovery of Influenza Polymerase PA–PB1 Interaction Inhibitors Using an In Vitro Split-Luciferase Complementation-Based Assay
- (2019) Jiantao Zhang et al. ACS Chemical Biology
- Chemical Genomics Approach Leads to the Identification of Hesperadin, an Aurora B Kinase Inhibitor, as a Broad-Spectrum Influenza Antiviral
- (2017) Yanmei Hu et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Combination therapy in combating cancer
- (2017) Reza Bayat Mokhtari et al. Oncotarget
- Mimics of Host Defense Proteins; Strategies for Translation to Therapeutic Applications
- (2016) Richard W. Scott et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- An Independent Evaluation of a Novel Peptide Mimetic, Brilacidin (PMX30063), for Ocular Anti-Infective
- (2016) Regis P. Kowalski et al. JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS
- Middle East respiratory syndrome
- (2015) Alimuddin Zumla et al. LANCET
- Comparative Mechanistic Studies of Brilacidin, Daptomycin, and the Antimicrobial Peptide LL16
- (2014) Bruk Mensa et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Human Coronavirus NL63 Utilizes Heparan Sulfate Proteoglycans for Attachment to Target Cells
- (2014) A. Milewska et al. JOURNAL OF VIROLOGY
- A Human Coronavirus Responsible for the Common Cold Massively Kills Dendritic Cells but Not Monocytes
- (2012) M. Mesel-Lemoine et al. JOURNAL OF VIROLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now